title: Cathepsin K inhibitors: emerging treatment options for osteoporosis.
authors.affiliation: Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria, peter.pietschmann@meduniwien.ac.at.
authors.forename: Peter
authors.initials: P
authors.lastname: Pietschmann
mesh_terms: D001713:Biphenyl Compounds / Q000627:therapeutic use*; D001842:Bone and Bones / Q000187:drug effects; D056657:Cathepsin K / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000517:prevention & control
chemical_list: D001713:Biphenyl Compounds; C534130:CTSK protein, human; D056657:Cathepsin K; C527128:odanacatib